MODIFICATION OF INTERPERSONAL PSYCHOTHERAPY WITH DEPRESSED ADOLESCENTS (IPT-A) - PHASE-I AND PHASE-II STUDIES

被引:69
|
作者
MUFSON, L [1 ]
MOREAU, D [1 ]
WEISSMAN, MM [1 ]
WICKRAMARATNE, P [1 ]
MARTIN, J [1 ]
SAMOILOV, A [1 ]
机构
[1] COLUMBIA UNIV COLL PHYS & SURG, CHILDRENS ANXIETY & DEPRESS CLIN, NEW YORK, NY 10032 USA
关键词
ADOLESCENCE; DEPRESSION; INTERPERSONAL PSYCHOTHERAPY;
D O I
10.1097/00004583-199406000-00011
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Objective: To test the acceptability and efficacy of interpersonal psychotherapy for depressed adolescents (IPT-A). Method: in phase I, therapeutic methods were explored and refined in a small sample of depressed adolescents (n = 5). In phase II, 14 depressed adolescents entered a 12-week open clinical trial of IPT-A; after independent evaluation. Subjects were assessed using a semistructured diagnostic interview, self-report, and clinician-administered instruments, at six time points: evaluation week, and weeks 0, 2, 4, 8, and 12. Results: in phase I, treatment was modified to meet the needs of an adolescent population and was standardized in a treatment manual. The results of phase II indicated a significant decrease in adolescents' depressive symptomatology and symptoms of psychological and physical distress, as well as a significant improvement in functioning over the course of treatment. At termination, none of the subjects met DSM-III-R criteria for any depressive disorder. Conclusions: IPT-A appears to be a promising therapy for depressed adolescents. However, because of the limitations of the current study, a larger randomized controlled clinical trial is still needed to test its efficacy.
引用
收藏
页码:695 / 705
页数:11
相关论文
共 50 条
  • [31] A COMPREHENSIVE PHASE-I AND PHASE-II CLINICAL INVESTIGATION OF FLUDARABINE PHOSPHATE
    GREVER, M
    LEIBY, J
    KRAUT, E
    METZ, E
    NEIDHART, J
    BALCERZAK, S
    MALSPEIS, L
    SEMINARS IN ONCOLOGY, 1990, 17 (05) : 39 - 48
  • [32] PHASE-I PHASE-II PREVENTIVE VACCINE TRIALS - CONFERENCE SUMMARY
    WALKER, MC
    FAST, PE
    GRAHAM, BS
    BELSHE, R
    DOLIN, R
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (10) : 1279 - 1285
  • [34] GENERATION OF PHASE-I AND PHASE-II OF MIGRATING MYOELECTRIC COMPLEX IN THE DOG
    LANG, IM
    SARNA, SK
    CONDON, RE
    AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (02): : G201 - G207
  • [35] PYRIDINIUM PICRATE - THE STRUCTURES OF PHASE-I AND PHASE-II - CORRECTION OF PREVIOUS REPORT FOR PHASE-I - STUDY OF THE PHASE-TRANSFORMATION
    BOTOSHANSKY, M
    HERBSTEIN, FH
    KAPON, M
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1994, 50 : 191 - 200
  • [36] GROWTH OF AMMONIUM-NITRATE PHASE-I AND PHASE-II DENDRITES
    VANDRIEL, CA
    VANDERHEIJDEN, AEDM
    VANROSMALEN, GM
    JOURNAL OF CRYSTAL GROWTH, 1993, 128 (1-4) : 229 - 233
  • [37] PHASE-I, PHASE-II CLINICAL-TRIALS WITH CARCINOMA OF THE PANCREAS
    GARCES, R
    SCANLON, E
    PRASAD, SG
    KHANDEKAR, JD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (10): : 1828 - 1828
  • [38] COMPARISON OF PHASE-I AND PHASE-II METABOLISM IN LIVER-DISEASE
    HOYUMPA, A
    ERMER, J
    CEVALLOS, W
    TREVINO, H
    MARTIN, R
    BAY, M
    GONZALEZ, R
    VAVRA, I
    CHIANG, S
    HEPATOLOGY, 1990, 12 (02) : 412 - 412
  • [39] PREREQUISITES FOR PHASE-I AND PHASE-II OF DRUG CLINICAL-TRIALS
    JAILLON, P
    DUPUIS, B
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1989, 82 (10): : 1773 - 1776
  • [40] CLINICAL PHASE-I AND PHASE-II TRIAL OF CIS PLATINUM (CDDP) AND PRE-CLINICAL AND CLINICAL PHASE-I STUDIES OF MALONATO PLATINUM (MDP)
    MATHE, G
    HAYAT, M
    GIRALT, E
    SZPIRGLAS, H
    BAYSSAS, M
    GOUVEIA, J
    RIBAUD, P
    MISSET, JL
    MACHOVER, D
    BIOCHIMIE, 1978, 60 (09) : 1062 - 1063